Home › Cancer (all types) › Kentucky
Cancer (all types) clinical trials in Kentucky
27 studies for Cancer (all types) are looking for participants at sites in Kentucky.
Cities in Kentucky
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
- Saint Elizabeth Healthcare Edgewood, Edgewood
- Baptist Health Lexington, Lexington
RecruitingPhase 3
Ages 18 and older · Women · Updated Sep 28, 2026 · NCT05256225A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- University of Kentucky Research Foundation, Lexington
- University of Kentucky Healthcare - Markey Cancer Center, Lexington
- University of Kentucky Medical Center, Lexington
- and 1 more
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06989437A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- Saint Elizabeth Medical Center Edgewood, Edgewood
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06901531A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Baptist Health Louisville /ID# 280025, Louisville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07365241Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 18, Lexington
RecruitingPhase 3
Ages 18 to 71 · All sexes · Updated Sep 23, 2026 · NCT07504458Pan Tumor Rollover Study
- University of Louisville-James Graham Brown Cancer Center, Louisville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03899155Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)
- University of Kentucky, Lexington
RecruitingObservational study
All ages · All sexes · Updated Sep 21, 2026 · NCT06423950Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- University Of Kentucky, Lexington
- Norton Cancer Institute Louisville Oncology, Louisville
RecruitingPhase 2/3
All ages · All sexes · Updated Sep 18, 2026 · NCT03435796Massage, Oncology, Pain, Anxiety, Feasibility
- University of Kentucky, Lexington
Recruiting
Ages 18 to 85 · Women · Updated Sep 10, 2026 · NCT07502157A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
- Research Site, Edgewood
- Research Site, Louisville
RecruitingPhase 3
Ages 18 to 130 · All sexes · Updated Sep 8, 2026 · NCT07647328A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- CHI Saint Joseph Cancer Center - East, Lexington
- University of Kentucky Chandler Medical Center, Lexington
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06119581Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
- Pikeville Medical Center, Pikeville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06252649A Study of ARC-02 in B-cell NHL
- Norton Cancer Institute, Louisville
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT07691606Project: Every Child for Younger Patients With Cancer
- University of Kentucky/Markey Cancer Center, Lexington
- Norton Children's Hospital, Louisville
RecruitingObservational study
Up to age 25 · All sexes · Updated Aug 25, 2026 · NCT02402244Abatacept in Immune Checkpoint Inhibitor Myocarditis
- University of Kentucky, Lexington
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT05335928Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- CommonSpirit Saint Joseph Hospital - Bardstown, Bardstown
- Baptist Health Corbin, Corbin
- Commonwealth Cancer Center-Corbin, Corbin
- and 10 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT06580314Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Norton Cancer Institute, Louisville
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 29, 2026 · NCT04198766A Study of ASP1002 in Adults for Treatment of Solid Tumors
- Norton Cancer Institute, Louisville
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 23, 2026 · NCT05719558Impact of Daily Oral Cannabis Doses in Patients With Cancer
- University of Kentucky, Lexington
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 15, 2026 · NCT06601218EXoPERT EMERALD Clinical Study
- Lexington VA Healthcare System, Lexington
- KCTL, Louisville
RecruitingObservational studyHealthy volunteers welcome
Ages 45 and older · All sexes · Updated Jul 1, 2026 · NCT07186296Comprehensive Connected Cancer Care (C4): Intervention Evaluation
- University of Kentucky, Lexington
Recruiting
Ages 18 and older · All sexes · Updated Jun 22, 2026 · NCT06326567Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- Robley Rex VA Medical Center, Louisville, KY, Louisville
Recruiting
Ages 18 to 75 · All sexes · Updated Jun 17, 2026 · NCT05486572A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
- University of Louisville, Louisville
RecruitingPhase 1/2
Ages 18 to 70 · All sexes · Updated Jun 11, 2026 · NCT05361174Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
- Markey Cancer Center, University of Kentucky, Lexington
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 27, 2026 · NCT03089554Beat Childhood Cancer Specimen Banking and Data Registry
- Norton Children's Research Institute/Affiliated with University of Louisville School of Medicine, Louisville
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Feb 3, 2026 · NCT04715178Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
- Norton Cancer Institute, Louisville
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Dec 19, 2025 · NCT05270213Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- University of Kentucky, Lexington
Recruiting
Ages 18 and older · All sexes · Updated Nov 27, 2024 · NCT03860883From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.